Flutoprazepam Market

Global Flutoprazepam Market by Diseases (Anxiety, insomnia, stomach ulcers, and others), End-users (Adult and Children), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

  • Report ID: HC-3859
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 215
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global Flutoprazepam market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028.

Flutoprazepam is a benzodiazepine which is available in Japan. It shows hypnotic, anxiolytic, anticonvulsant and sedative effects. It is used for the treatment for stomach ulcers and severe insomnia. Flutoprazepam does not fall under the international Convention on Psychotropic Substances of 1971 and is currently unscheduled in the United States. Benzodiazepines act as central nervous system depressants by boosting the activities of the neurotransmitter gamma-aminobutyric acid (GABA) on the benzodiazepine site of the GABA type A (GABAA) receptor. Anxiolytic and sedative effects, muscular relaxation, and anticonvulsive activity are among their effects.

Flutoprazepam Market Key Takeaways

Flutoprazepam is currently unregulated in the United States because it does not fall under the 1971 International Convention on Psychotropic Substances. Flutoprazepam is classified as a Class C-Schedule II drug, according to the Misuse of Drugs Act, in Singapore and a Schedule III psychotic substance in Thailand. Flutoprazepam is regulated in Hong Kong under Schedule 1 of the Chapter 134 Dangerous Drugs Ordinance. Only health professionals and university researchers are allowed to use flutoprazepam legally. Pharmacists can dispense the drug with a prescription. A punishment of $10000 (HKD) might be imposed on anyone who supplies the substance without a prescription. A fine of $5,000,000 (HKD) and life imprisonment are the penalties for trafficking or manufacturing the chemical. Possession of the substance for human consumption without a Department of Health licence is prohibited by a penalty of $1,000,000 (HKD) and/or seven years in prison.

Market Trends, Drivers, Restraints, and Opportunities:

  • Increasing demand for Flutoprazepam from the pharmaceutical industry increase in prevalence of anxiety, seizures, insomnia is fueling the market growth.
  • Rise in concern for prevention of stress and related conditions is also driving the market.
  • This drug is not regulated in many regions, which in turn, is expected to hamper the market growth.

Scope of the report:

The report on Flutoprazepam market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Flutoprazepam Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

By Diseases (Anxiety, insomnia, stomach ulcers, and others), End-users (Adult and Children)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Cayman Chemical and DC Chemicals Ltd

Flutoprazepam Market Segment Insights:

The Anxiety segment is projected to hold significant market share

In the terms of diseases, the Flutoprazepam market can be segmented into anxiety, insomnia, stomach ulcers, and others. Anxiety disorders segment is expected to hold a significant market share in the benzodiazepine drugs. According to the World Health Organization (WHO), the projected number of persons living with anxiety disorders worldwide is 264 million in 2015. This is a 14.9 percent increase since 2005, owing to population growth and ageing. Females are more likely than males to suffer from anxiety disorders (4.6 percent in females compared to 2.6 percent in males at the global level). In 2017, anxiety was a major section of the worldwide benzodiazepine medication market, and this trend is projected to continue during the forecast period.

Flutoprazepam Market By Diseases

Adults segment to grow during the forecast period

On the basis of end-users, the market can be bifurcated into adults and children. The adult segment is expected to hold a significant share of the market during the forecast period due to increase in geriatric population and rise of population suffering from stress.

Asia Pacific dominates the global market

In terms of regions, the global Flutoprazepam market can be split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific constituted a significant share of the market in 2020 due to mergers and acquisitions conducted by key market players. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing prevalence of anxiety among population.

Flutoprazepam Market By Regions

Segments

Segments Covered in the Report
Diseases
  • Anxiety
  • Insomnia
  • Stomach ulcers
  • Others
End-users
  • Adults
  • Children
Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa
Key Players
  • Cayman Chemical
  • DC Chemicals Ltd

Competitive Landscape

Key players in the Flutoprazepam market include Cayman Chemical and DC Chemicals Ltd. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Flutoprazepam Market By Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Flutoprazepam Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Flutoprazepam Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Flutoprazepam Market - Supply Chain
  4.5. Global Flutoprazepam Market Forecast
     4.5.1. Flutoprazepam Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Flutoprazepam Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Flutoprazepam Market Absolute $ Opportunity
5. Global Flutoprazepam Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Flutoprazepam Market Size and Volume Forecast by End Users
     5.3.1. Adults Children
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Flutoprazepam Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Flutoprazepam Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Flutoprazepam Demand Share Forecast, 2019-2026
7. North America Flutoprazepam Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Flutoprazepam Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Flutoprazepam Market Size and Volume Forecast by End Users
     7.4.1. Adults Children
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Flutoprazepam Demand Share Forecast, 2019-2026
8. Latin America Flutoprazepam Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Flutoprazepam Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Flutoprazepam Market Size and Volume Forecast by End Users
     8.4.1. Adults Children
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Flutoprazepam Demand Share Forecast, 2019-2026
9. Europe Flutoprazepam Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Flutoprazepam Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Flutoprazepam Market Size and Volume Forecast by End Users
     9.4.1. Adults Children
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Flutoprazepam Demand Share Forecast, 2019-2026
10. Asia Pacific Flutoprazepam Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Flutoprazepam Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Flutoprazepam Market Size and Volume Forecast by End Users
     10.4.1. Adults Children
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Flutoprazepam Demand Share Forecast, 2019-2026
11. Middle East & Africa Flutoprazepam Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Flutoprazepam Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Flutoprazepam Market Size and Volume Forecast by End Users
     11.4.1. Adults Children
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Flutoprazepam Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Flutoprazepam Market: Market Share Analysis
  12.2. Flutoprazepam Distributors and Customers
  12.3. Flutoprazepam Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Cayman Chemical DC Chemicals Ltd
Segments Covered in the Report
Diseases
  • Anxiety
  • Insomnia
  • Stomach ulcers
  • Others
End-users
  • Adults
  • Children
Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa
Key Players
  • Cayman Chemical
  • DC Chemicals Ltd

Key players in the Flutoprazepam market include Cayman Chemical and DC Chemicals Ltd. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Flutoprazepam Market By Key Players

Buy Report